Clinical implications of antigen transfer mechanisms from malignant to dendritic cells
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Experimental Hematology
- Vol. 30 (12) , 1355-1364
- https://doi.org/10.1016/s0301-472x(02)00956-6
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12Experimental Hematology, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitorsThe Journal of Gene Medicine, 2000
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- The Hallmarks of CancerCell, 2000
- Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte ResponseThe Journal of Experimental Medicine, 1999
- Dendritic Cell Survival and Maturation Are Regulated by Different Signaling PathwaysThe Journal of Experimental Medicine, 1998
- Two signal models of lymphocyte activation?Immunology Today, 1993
- The two-signal model of lymphocyte activation twenty-one years laterImmunology Today, 1992
- Two signal model of lymphocyte activationImmunology Today, 1992